US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALLURION TECHNOLOGIES

2.43

+0.02000.83%

Volume:38.83K

Turnover:94.73K

Market Cap:18.12M

PE:-0.24

High:2.49

Open:2.41

Low:2.40

Close:2.41

Loading ...

Overview Company News Filings

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion Technologies Enters Agreement for Private Placement of Shares to Raise $2.5 Million From RTW Investments

MT Newswires Live

Allurion Technologies Shares Rise 13% After Private Placement Extends Runway

Nyse Halt Allurion Tch Ord Add Info Lst $3.890000

THOMSON REUTERS

Allurion Technologies to sell 841,751 shares at $2.97 in private placement

BRIEF-Allurion Announces Private Placement Of Common Stock And Preliminary Unaudited Financial Results For The Fourth Quarter And Fiscal Year 2024

Allurion Technologies Inc - Expects Q4 2024 Revenue of $5.6 Million, Full Year $32 Million

THOMSON REUTERS

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

THOMSON REUTERS

Allurion Technologies Inc - Private Placement Expected to Result in $2.5 Million Gross Proceeds

THOMSON REUTERS

Press Release: Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

BRIEF-Allurion Reports Positive Topline Results From AUDACITY Trial

Allurion announces AUDACITY trial meets one co-primary endpoint, misses other

Allurion Announces Positive Topline Results From Audacity Trial

THOMSON REUTERS

Allurion Technologies Inc - Audacity Trial Achieves Responder Rate Co-Primary Endpoint

THOMSON REUTERS

Allurion Technologies Inc - Serious Adverse Events Rate in Allurion Balloon Subjects at 3.1%

THOMSON REUTERS

Allurion Technologies Inc - Balloon Subjects Show Greater Weight Loss at 48 Weeks VS Control Subjects

THOMSON REUTERS

Allurion: Fourth and Final Module of Pma Submission Including Audacity Trial Data Planned for 2025

THOMSON REUTERS

Allurion Announces Positive Topline Results From AUDACITY Trial

Allurion Technologies Inc trading resumes

Allurion Technologies Inc trading halted, volatility trading pause

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALUR/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALUR\",,,,,undefined,":{"symbol":"ALUR","market":"US","secType":"STK","nameCN":"ALLURION TECHNOLOGIES","latestPrice":2.43,"timestamp":1750795200000,"preClose":2.41,"halted":0,"volume":38832,"delay":0,"floatShares":4079800,"shares":7457758,"eps":-10.261535,"marketStatus":"Pre-Mkt","change":0.02,"latestTime":"06-25 06:33:14 EDT","open":2.41,"high":2.49,"low":2.4,"amount":94728.3068976,"amplitude":0.037344,"askPrice":2.65,"askSize":100,"bidPrice":2.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-10.261535,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750858200000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":2.41,"postHourTrading":{"tag":"盘后","latestPrice":2.4,"preClose":2.43,"latestTime":"19:39 EDT","volume":1403,"amount":3373.21,"timestamp":1750808366873},"volumeRatio":0.6595243111814522,"impliedVol":0.5858,"impliedVolPercentile":0.3258},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALUR\",,,,,undefined,":{"symbol":"ALUR","floatShares":4079800,"roa":"-52.20%","roe":"--","lyrEps":-11.635999,"volumeRatio":0.6595243111814522,"shares":7457758,"dividePrice":0,"high":2.49,"amplitude":0.037344,"preClose":2.41,"low":2.4,"week52Low":2.15,"pbRate":"-0.26","psRate":"0.64","week52High":57.25,"institutionHeld":0,"latestPrice":2.43,"eps":-10.261535,"divideRate":0,"volume":38832,"delay":0,"ttmEps":-10.261535,"open":2.41,"prevYearClose":10.75,"prevWeekClose":2.32,"prevMonthClose":2.66,"prevQuarterClose":3.21,"fiveDayClose":2.44,"twentyDayClose":2.79,"sixtyDayClose":3.2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALUR\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2505827564","title":"Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2505827564","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505827564?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:30","pubTimestamp":1737466200,"startTime":"0","endTime":"0","summary":"NATICK, Mass., January 21, 2025----Allurion Technologies, Inc.  , a company dedicated to ending obesity, today announced that it has received an Issue Notification from the U.S. Patent and Trademark Office  dated January 15, 2025 for U.S. Patent No. 12,209,677 titled \"Binary Fluid Control Valve System\". This patent covers additional claims for an enhanced, next-generation version of Allurion’s proprietary Balloon technology and the introduction of innovative features, particularly to the precision of the valve system that controls balloon opening. The patent is expected to provide protection through July 2039. With the issuance of this patent, the Company now has 20 patents issued in the U.S. and 59 patents issued globally.The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss with the Allurion Virtual Care Suite, including the Allurion Mobile App and Connected Sca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allurion-announces-notification-issuance-u-133000705.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4192","ALUR"],"gpt_icon":1},{"id":"2503629988","title":"Allurion Technologies Enters Agreement for Private Placement of Shares to Raise $2.5 Million From RTW Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2503629988","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503629988?lang=en_us&edition=fundamental","pubTime":"2025-01-16 00:05","pubTimestamp":1736957143,"startTime":"0","endTime":"0","summary":"Allurion Technologies  said Tuesday it has entered into a subscription agreement for a private placement of 841,751 of its shares at $2.97 per share to raise $2.5 million from funds affiliated with RTW Investments.The placement includes an option for $10 million funding in additional tranches, according to Allurion.The company said it expects to close the placement Wednesday, and gross proceeds will extend its runway through early 2026. The company intends to use the funds for working capital and other general corporate purposes.Allurion also reported preliminary Q4 and 2024 revenue of about $5.6 million and $32 million. Four analysts polled by FactSet expect $5.6 million and $32.1 million.Shares of Allurion were up 3.2% in recent Wednesday trading.Price: 3.24, Change: +0.10, Percent Change: +3.18","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2503500871","title":"Allurion Technologies Shares Rise 13% After Private Placement Extends Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2503500871","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503500871?lang=en_us&edition=fundamental","pubTime":"2025-01-15 02:42","pubTimestamp":1736880120,"startTime":"0","endTime":"0","summary":"Allurion Technologies shares rose after agreeing to a private placement with expected gross proceeds of $2.5 million that will extend its runway through early 2026.The stock was up 13% to $3.37. The stock is down 96% in the last 52 weeks.The developer of obesity treatments entered into a subscription agreement with funds affiliated with RTW Investments for the purchase and sale of 841,751 shares of its common stock at a purchase price of $2.97 a share. The agreement also includes an option to fund up to an additional $10 million in subsequent tranches.The private placement is expected to close on or about Wednesday.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2503740555","title":"Nyse Halt Allurion Tch Ord  Add Info Lst $3.890000","url":"https://stock-news.laohu8.com/highlight/detail?id=2503740555","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503740555?lang=en_us&edition=fundamental","pubTime":"2025-01-14 23:07","pubTimestamp":1736867225,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nAQN2JXT16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2503277579","title":"Allurion Technologies to sell 841,751 shares at $2.97 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2503277579","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503277579?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:26","pubTimestamp":1736864761,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced that it has entered into a subscription agreement with funds affiliated with RTW Investments for the purchas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-to-sell-841751-shares-at-2-97-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-to-sell-841751-shares-at-2-97-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2503576743","title":"BRIEF-Allurion Announces Private Placement Of Common Stock And Preliminary Unaudited Financial Results For The Fourth Quarter And Fiscal Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503576743","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503576743?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:22","pubTimestamp":1736864570,"startTime":"0","endTime":"0","summary":"BRIEF-Allurion Announces Private Placement Of Common Stock And Preliminary Unaudited Financial Results For The Fourth Quarter And Fiscal Year 2024Jan 14 (Reuters) - Allurion Technologies Inc ALUR.N:AL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB6LGMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192"],"gpt_icon":1},{"id":"2503657694","title":"Allurion Technologies Inc - Expects Q4 2024 Revenue of $5.6 Million, Full Year $32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2503657694","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503657694?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:18","pubTimestamp":1736864280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB6LGMV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2503576949","title":"Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503576949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503576949?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:18","pubTimestamp":1736864280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB6LGMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2503576943","title":"Allurion Technologies Inc - Private Placement Expected to Result in $2.5 Million Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2503576943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503576943?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:18","pubTimestamp":1736864280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB6LGMV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2503576226","title":"Press Release: Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503576226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503576226?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:18","pubTimestamp":1736864280,"startTime":"0","endTime":"0","summary":"Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024. The securities sold in the private placement are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended , or any state or other applicable jurisdiction's securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions' securit","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4099","TM","03160","BK4192","BK4585","BK4588","BK4555"],"gpt_icon":0},{"id":"2501720900","title":"BRIEF-Allurion Reports Positive Topline Results From AUDACITY Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2501720900","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501720900?lang=en_us&edition=fundamental","pubTime":"2025-01-08 22:04","pubTimestamp":1736345049,"startTime":"0","endTime":"0","summary":"Jan 8  - Allurion Technologies Inc   :   * ALLURION ANNOUNCES POSITIVE TOPLINE RESULTS FROM AUDACITY TRIAL   * ALLURION TECHNOLOGIES INC - AUDACITY TRIAL ACHIEVES RESPONDER RATE CO-PRIMARY ENDPOINT   * ALLURION TECHNOLOGIES INC - SERIOUS ADVERSE EVENTS RATE IN ALLURION BALLOON SUBJECTS AT 3.1%   * ALLURION TECHNOLOGIES INC - BALLOON SUBJECTS SHOW GREATER WEIGHT LOSS AT 48 WEEKS VERSUS CONTROL SUBJECTS   * ALLURION: FOURTH AND FINAL MODULE OF PMA SUBMISSION INCLUDING AUDACITY TRIAL DATA PLANNED FOR 2025Source text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2501724232","title":"Allurion announces AUDACITY trial meets one co-primary endpoint, misses other","url":"https://stock-news.laohu8.com/highlight/detail?id=2501724232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501724232?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:16","pubTimestamp":1736342162,"startTime":"0","endTime":"0","summary":"Allurion Technologies (ALUR) announced topline results from the AUDACITY FDA pivotal trial evaluating the safety and efficacy of the Allurion Ballo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-announces-audacity-trial-meets-one-co-primary-endpoint-misses-other?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-announces-audacity-trial-meets-one-co-primary-endpoint-misses-other?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2501721913","title":"Allurion Announces Positive Topline Results From Audacity Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721913?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA9LHGF5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2501721642","title":"Allurion Technologies Inc - Audacity Trial Achieves Responder Rate Co-Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721642?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA9LHGF5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2501721638","title":"Allurion Technologies Inc - Serious Adverse Events Rate in Allurion Balloon Subjects at 3.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721638?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA9LHGF5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2501272192","title":"Allurion Technologies Inc - Balloon Subjects Show Greater Weight Loss at 48 Weeks VS Control Subjects","url":"https://stock-news.laohu8.com/highlight/detail?id=2501272192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501272192?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA9LHGF5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2501172117","title":"Allurion: Fourth and Final Module of Pma Submission Including Audacity Trial Data Planned for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501172117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501172117?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA9LHGF5:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2501724086","title":"Allurion Announces Positive Topline Results From AUDACITY Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2501724086","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501724086?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341200,"startTime":"0","endTime":"0","summary":"At 48 weeks, Allurion Balloon subjects had a greater than 50% responder rate and substantially greater weight loss than Control subjects. Low rate of serious adverse events supports favorable safety profile of the Allurion Balloon. Fourth and final module of PMA submission including AUDACITY trial data planned for 2025. NATICK, Mass., January 08, 2025----Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced topline results from the AUDACITY Food & Drug Administration  pivotal trial evaluating the safety and efficacy of the Allurion Balloon.The rate of serious adverse events in Allurion Balloon subjects in the AUDACITY trial was 3.1%, the lowest reported in a pivotal FDA trial for a liquid-filled intragastric balloon indicated for weight loss.2. \"I believe the results of the AUDACITY trial demonstrate a favorable benefit-risk profile for people with obesity,\" said Dr. Shelby Sullivan, Professor of Medicine and Director, Endoscopic Bariatric and Metabolic P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allurion-announces-positive-topline-results-130000579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4192","ALUR"],"gpt_icon":0},{"id":"2500125141","title":"Allurion Technologies Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2500125141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500125141?lang=en_us&edition=fundamental","pubTime":"2025-01-04 04:05","pubTimestamp":1735934706,"startTime":"0","endTime":"0","summary":"15:03 EST Allurion Technologies (ALUR) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-inc-trading-resumes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-inc-trading-resumes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALUR","BK4192"],"gpt_icon":0},{"id":"2500712511","title":"Allurion Technologies Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2500712511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500712511?lang=en_us&edition=fundamental","pubTime":"2025-01-04 04:00","pubTimestamp":1735934415,"startTime":"0","endTime":"0","summary":"14:58 EST Allurion Technologies (ALUR) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allurion-technologies-inc-trading-halted-volatility-trading-pause?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allurion-technologies-inc-trading-halted-volatility-trading-pause?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4192","ALUR"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":120,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ALUR","fiscalQuarterEnding":"2025/03","expectedEps":-1.53,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":0.43},{"market":"US","date":"2025-03-26","symbol":"ALUR","fiscalQuarterEnding":"2024/12","expectedEps":5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":7},{"market":"US","date":"2025-01-14","symbol":"ALUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1736830800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-01-03","symbol":"ALUR","defaultRemindTime":1735914600000,"type":"split","dateTimestamp":1735880400000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2024-11-13","symbol":"ALUR","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALUR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1731643200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALUR","date":"2025-06-24","current":-0.737967,"percent":0.867391,"low":-4.394257,"twenty":-2.168474,"median":-1.201238,"eighty":-0.837504,"high":-0.310901,"avg":-1.497276,"sd":0.830153,"marketCap":17973196},"quantilePoints":[{"date":"2023-08-18","current":-2.037917,"twenty":-3.277082,"median":-2.839759,"eighty":-2.134151,"marketCap":133925760},{"date":"2023-08-25","current":-2.236047,"twenty":-2.898447,"median":-2.214819,"eighty":-2.105847,"marketCap":146946320},{"date":"2023-09-01","current":-2.816287,"twenty":-2.825676,"median":-2.250199,"eighty":-2.144058,"marketCap":185077960},{"date":"2023-09-08","current":-3.382375,"twenty":-3.27846,"median":-2.504939,"eighty":-2.172362,"marketCap":222279560},{"date":"2023-09-15","current":-3.86355,"twenty":-3.420586,"median":-2.839759,"eighty":-2.196421,"marketCap":253900920},{"date":"2023-09-22","current":-3.849398,"twenty":-3.840907,"median":-3.25425,"eighty":-2.214819,"marketCap":252970880},{"date":"2023-09-29","current":-2.986114,"twenty":-3.811187,"median":-3.133201,"eighty":-2.247369,"marketCap":196238440},{"date":"2023-10-06","current":-3.346995,"twenty":-3.729104,"median":-3.240853,"eighty":-2.275674,"marketCap":219954460},{"date":"2023-10-13","current":-3.12056,"twenty":-3.596073,"median":-3.233777,"eighty":-2.462482,"marketCap":205073820},{"date":"2023-10-20","current":-3.127636,"twenty":-3.515406,"median":-3.279772,"eighty":-2.734205,"marketCap":205538840},{"date":"2023-10-27","current":-3.118177,"twenty":-3.506915,"median":-3.247929,"eighty":-2.751188,"marketCap":204917216},{"date":"2023-11-03","current":-3.160601,"twenty":-3.44606,"median":-3.226701,"eighty":-2.804965,"marketCap":207705205},{"date":"2023-11-10","current":-3.026258,"twenty":-3.414926,"median":-3.168884,"eighty":-2.835065,"marketCap":198876572},{"date":"2023-11-17","current":-2.73411,"twenty":-3.405019,"median":-3.127636,"eighty":-2.780397,"marketCap":201708999},{"date":"2023-11-24","current":-2.498541,"twenty":-3.403604,"median":-3.118177,"eighty":-2.727355,"marketCap":184329841},{"date":"2023-12-01","current":-2.401948,"twenty":-3.390867,"median":-3.062787,"eighty":-2.517859,"marketCap":177203687},{"date":"2023-12-08","current":-2.131487,"twenty":-3.378129,"median":-3.042723,"eighty":-2.431569,"marketCap":157250457},{"date":"2023-12-15","current":-2.211861,"twenty":-3.366808,"median":-3.022722,"eighty":-2.28228,"marketCap":163180039},{"date":"2023-12-22","current":-2.284298,"twenty":-3.361147,"median":-2.969692,"eighty":-2.258787,"marketCap":168524069},{"date":"2023-12-29","current":-2.50951,"twenty":-3.358317,"median":-2.963751,"eighty":-2.253222,"marketCap":185139119},{"date":"2024-01-05","current":-2.174909,"twenty":-3.349825,"median":-2.941409,"eighty":-2.243761,"marketCap":160453903},{"date":"2024-01-12","current":-2.168474,"twenty":-3.341334,"median":-2.806389,"eighty":-2.214533,"marketCap":159979187},{"date":"2024-01-19","current":-2.039781,"twenty":-3.322936,"median":-2.772628,"eighty":-2.209949,"marketCap":150484873},{"date":"2024-01-26","current":-1.969,"twenty":-3.307368,"median":-2.73411,"eighty":-2.194213,"marketCap":145263001},{"date":"2024-02-02","current":-1.904654,"twenty":-3.300292,"median":-2.63612,"eighty":-2.172335,"marketCap":140515844},{"date":"2024-02-09","current":-1.904654,"twenty":-3.276234,"median":-2.50951,"eighty":-2.159537,"marketCap":140515844},{"date":"2024-02-16","current":-1.853177,"twenty":-3.245099,"median":-2.495321,"eighty":-2.128024,"marketCap":136718118},{"date":"2024-02-23","current":-1.769526,"twenty":-3.232789,"median":-2.427706,"eighty":-2.053281,"marketCap":130546814},{"date":"2024-03-01","current":-2.06552,"twenty":-3.229465,"median":-2.380817,"eighty":-2.023593,"marketCap":152383736},{"date":"2024-03-08","current":-1.737353,"twenty":-3.214402,"median":-2.288477,"eighty":-1.984444,"marketCap":128173236},{"date":"2024-03-15","current":-1.756657,"twenty":-3.18844,"median":-2.276159,"eighty":-1.962566,"marketCap":129597383},{"date":"2024-03-22","current":-1.183742,"twenty":-3.170541,"median":-2.265535,"eighty":-1.935541,"marketCap":95417853},{"date":"2024-03-28","current":-1.041238,"twenty":-3.155121,"median":-2.2545,"eighty":-1.923958,"marketCap":83931048},{"date":"2024-04-05","current":-1.828437,"twenty":-3.132088,"median":-2.24569,"eighty":-1.904654,"marketCap":147384785},{"date":"2024-04-12","current":-1.406946,"twenty":-3.126221,"median":-2.216746,"eighty":-1.837734,"marketCap":113409721},{"date":"2024-04-19","current":-1.21222,"twenty":-3.120083,"median":-2.207082,"eighty":-1.808134,"marketCap":97713423},{"date":"2024-04-26","current":-1.099317,"twenty":-3.115349,"median":-2.19744,"eighty":-1.781109,"marketCap":88612663},{"date":"2024-05-03","current":-1.307296,"twenty":-3.098849,"median":-2.193591,"eighty":-1.739927,"marketCap":105377221},{"date":"2024-05-10","current":-1.2657,"twenty":-3.071976,"median":-2.171691,"eighty":-1.682015,"marketCap":102024309},{"date":"2024-05-17","current":-1.557002,"twenty":-3.046521,"median":-2.16204,"eighty":-1.465452,"marketCap":89091650},{"date":"2024-05-24","current":-1.290455,"twenty":-3.042723,"median":-2.15369,"eighty":-1.416683,"marketCap":73839846},{"date":"2024-05-31","current":-1.265316,"twenty":-3.042723,"median":-2.134707,"eighty":-1.40101,"marketCap":72401404},{"date":"2024-06-07","current":-1.055827,"twenty":-3.033328,"median":-2.091259,"eighty":-1.366719,"marketCap":60414417},{"date":"2024-06-14","current":-1.030688,"twenty":-3.026258,"median":-2.069526,"eighty":-1.340733,"marketCap":58975978},{"date":"2024-06-21","current":-1.910544,"twenty":-3.020601,"median":-2.05265,"eighty":-1.33065,"marketCap":109321326},{"date":"2024-06-28","current":-1.087116,"twenty":-2.992729,"median":-2.037917,"eighty":-1.30728,"marketCap":62204799},{"date":"2024-07-05","current":-1.303159,"twenty":-2.976261,"median":-1.988304,"eighty":-1.305592,"marketCap":74566772},{"date":"2024-07-12","current":-1.190818,"twenty":-2.969692,"median":-1.978652,"eighty":-1.272831,"marketCap":68138602},{"date":"2024-07-19","current":-0.960518,"twenty":-2.962562,"median":-1.962566,"eighty":-1.263093,"marketCap":54960853},{"date":"2024-07-26","current":-0.965686,"twenty":-2.947969,"median":-1.954567,"eighty":-1.217188,"marketCap":55256549},{"date":"2024-08-02","current":-0.946925,"twenty":-2.880419,"median":-1.930393,"eighty":-1.194393,"marketCap":54183044},{"date":"2024-08-09","current":-0.864803,"twenty":-2.825676,"median":-1.923958,"eighty":-1.182114,"marketCap":49484052},{"date":"2024-08-16","current":-1.135987,"twenty":-2.80441,"median":-1.911089,"eighty":-1.17509,"marketCap":42470010},{"date":"2024-08-23","current":-1.174714,"twenty":-2.789942,"median":-1.904654,"eighty":-1.164761,"marketCap":43917851},{"date":"2024-08-30","current":-1.13461,"twenty":-2.770038,"median":-1.88535,"eighty":-1.161461,"marketCap":42418531},{"date":"2024-09-06","current":-1.024109,"twenty":-2.753105,"median":-1.833873,"eighty":-1.157202,"marketCap":38287357},{"date":"2024-09-13","current":-1.058705,"twenty":-2.73959,"median":-1.818285,"eighty":-1.141628,"marketCap":39580762},{"date":"2024-09-20","current":-1.072991,"twenty":-2.727355,"median":-1.808134,"eighty":-1.134754,"marketCap":40114854},{"date":"2024-09-27","current":-1.076778,"twenty":-2.696024,"median":-1.78883,"eighty":-1.119463,"marketCap":40256421},{"date":"2024-10-04","current":-1.213441,"twenty":-2.641741,"median":-1.766276,"eighty":-1.118155,"marketCap":45365692},{"date":"2024-10-11","current":-1.187967,"twenty":-2.577103,"median":-1.743788,"eighty":-1.119463,"marketCap":44413334},{"date":"2024-10-18","current":-1.213441,"twenty":-2.522247,"median":-1.70518,"eighty":-1.121663,"marketCap":45365692},{"date":"2024-10-25","current":-1.308278,"twenty":-2.505122,"median":-1.643334,"eighty":-1.123413,"marketCap":48911294},{"date":"2024-11-01","current":-1.221117,"twenty":-2.498541,"median":-1.566981,"eighty":-1.127892,"marketCap":45652687},{"date":"2024-11-08","current":-1.272964,"twenty":-2.495965,"median":-1.462114,"eighty":-1.134754,"marketCap":47591037},{"date":"2024-11-15","current":-1.092904,"twenty":-2.47407,"median":-1.422056,"eighty":-1.134754,"marketCap":27060299},{"date":"2024-11-22","current":-1.369794,"twenty":-2.431569,"median":-1.420438,"eighty":-1.135377,"marketCap":33916100},{"date":"2024-11-29","current":-1.210797,"twenty":-2.407099,"median":-1.416149,"eighty":-1.136751,"marketCap":29979340},{"date":"2024-12-06","current":-1.190086,"twenty":-2.397722,"median":-1.40101,"eighty":-1.136751,"marketCap":29466535},{"date":"2024-12-13","current":-1.101188,"twenty":-2.376028,"median":-1.386169,"eighty":-1.134682,"marketCap":27265420},{"date":"2024-12-20","current":-0.910721,"twenty":-2.344028,"median":-1.373062,"eighty":-1.121079,"marketCap":22549443},{"date":"2024-12-27","current":-1.137877,"twenty":-2.292656,"median":-1.366719,"eighty":-1.118775,"marketCap":28173844},{"date":"2025-01-03","current":-0.83221,"twenty":-2.28597,"median":-1.365391,"eighty":-1.115457,"marketCap":20605525},{"date":"2025-01-10","current":-0.39988,"twenty":-2.284298,"median":-1.351275,"eighty":-1.102518,"marketCap":9901019},{"date":"2025-01-17","current":-0.406323,"twenty":-2.279415,"median":-1.335283,"eighty":-1.099866,"marketCap":10060568},{"date":"2025-01-24","current":-1.205103,"twenty":-2.274267,"median":-1.324577,"eighty":-1.093536,"marketCap":29838340},{"date":"2025-01-31","current":-1.138286,"twenty":-2.269544,"median":-1.32222,"eighty":-1.092252,"marketCap":28183963},{"date":"2025-02-07","current":-1.16926,"twenty":-2.265771,"median":-1.307255,"eighty":-1.093536,"marketCap":28950873},{"date":"2025-02-14","current":-0.996968,"twenty":-2.262035,"median":-1.303159,"eighty":-1.087243,"marketCap":24684933},{"date":"2025-02-21","current":-0.854769,"twenty":-2.256935,"median":-1.290455,"eighty":-1.084351,"marketCap":21164084},{"date":"2025-02-28","current":-0.765681,"twenty":-2.24949,"median":-1.277613,"eighty":-1.076503,"marketCap":18958250},{"date":"2025-03-07","current":-0.585096,"twenty":-2.24569,"median":-1.274523,"eighty":-1.069805,"marketCap":14486965},{"date":"2025-03-14","current":-0.573233,"twenty":-2.243761,"median":-1.265508,"eighty":-1.056403,"marketCap":14193246},{"date":"2025-03-21","current":-0.862258,"twenty":-2.232496,"median":-1.265316,"eighty":-1.043361,"marketCap":21349505},{"date":"2025-03-28","current":-0.729821,"twenty":-2.217673,"median":-1.25845,"eighty":-1.031687,"marketCap":19083356},{"date":"2025-04-04","current":-0.6614,"twenty":-2.214533,"median":-1.257286,"eighty":-1.02112,"marketCap":17294292},{"date":"2025-04-11","current":-0.554208,"twenty":-2.210905,"median":-1.243778,"eighty":-1.007359,"marketCap":14491424},{"date":"2025-04-17","current":-0.533682,"twenty":-2.207082,"median":-1.237015,"eighty":-0.99717,"marketCap":13954704},{"date":"2025-04-25","current":-0.547366,"twenty":-2.207082,"median":-1.227662,"eighty":-0.988379,"marketCap":14312517},{"date":"2025-05-02","current":-0.531401,"twenty":-2.200667,"median":-1.222611,"eighty":-0.975674,"marketCap":13895069},{"date":"2025-05-09","current":-0.542804,"twenty":-2.194213,"median":-1.219637,"eighty":-0.972876,"marketCap":14193246},{"date":"2025-05-16","current":-0.776204,"twenty":-2.194213,"median":-1.214364,"eighty":-0.946925,"marketCap":18904450},{"date":"2025-05-23","current":-0.722335,"twenty":-2.193591,"median":-1.213441,"eighty":-0.910721,"marketCap":17592469},{"date":"2025-05-30","current":-0.805334,"twenty":-2.18167,"median":-1.213441,"eighty":-0.891125,"marketCap":19613903},{"date":"2025-06-06","current":-0.826768,"twenty":-2.176989,"median":-1.212056,"eighty":-0.87515,"marketCap":20135946},{"date":"2025-06-13","current":-0.783899,"twenty":-2.17524,"median":-1.210797,"eighty":-0.86076,"marketCap":19091860},{"date":"2025-06-20","current":-0.74103,"twenty":-2.171048,"median":-1.205103,"eighty":-0.846888,"marketCap":18047774},{"date":"2025-06-24","current":-0.737967,"twenty":-2.168474,"median":-1.201238,"eighty":-0.837504,"marketCap":17973196}],"updateTime":1750847594510}}}